BIOMERICA, INC. (BMRA) Gross margin 2017–2026
BIOMERICA, INC. (BMRA) gross margin by fiscal year — reported gross profit divided by reported revenue.
8.1%FY2026 · since FY2017: 34.9% → 8.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 8.1% | -1.2 pp |
| FY2025 | 9.4% | -1.9 pp |
| FY2024 | 11.3% | +2.9 pp |
| FY2023 | 8.4% | -7.4 pp |
| FY2022 | 15.8% | +10.7 pp |
| FY2021 | 5.1% | -20.9 pp |
| FY2020 | 26.0% | +1.1 pp |
| FY2019 | 24.8% | -6.7 pp |
| FY2018 | 31.5% | -3.4 pp |
| FY2017 | 34.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BMRA financial trends
BMRA RevenueBMRA Net incomeBMRA Net marginBMRA Gross profitBMRA Operating incomeBMRA Operating marginBMRA Operating cash flowBMRA Free cash flowBMRA Capital expendituresBMRA Return on equityBMRA Stock buybacksBMRA Dividends paidBMRA Total assetsBMRA Total liabilitiesBMRA Shareholders’ equityBMRA overview →